OMX30 1 472 -0,5%  OMXH25 3 810 0,1%  Bitcoin 3 294,37 1,2%  Dow 24 101 -2,0%  Nas 6 595 -2,6%  EUR 10,2471 0,0%  USD 9,0604 0,0%  Olja 60,3 -2,4%  Guld 1 238 -0,3% 

Edwards Lifesciences Aktie

160,05USD -4,02USD -2,45%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
Obligationer
>

Edwards Lifesciences Chart - 1 1 år - BTT

Fundamentala nyckeltal för Edwards Lifesciences

2017 2018e 2019e 2020e 2021e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 29,95 35,53 32,21 28,68 25,98
Resultat/aktie 3,80 4,70 5,18 5,82 6,43

Nyheter om Edwards Lifesciences Corp.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Edwards Lifesciences Corp.

ytterligare analyser

Edwards Lifesciences Peer Group

Edwards Lifesciences 160,05
-2,5%
pagehit

Lägg till instrument

Vad tycker du?

Profil Edwards Lifesciences Corp.till bolagsprofilen

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..

Realtidskurs Edwards Lifesciences Corp.

Bid 156,00 USD Ask 169,96 USD
Tid 21:59 Börsen BTT

Aktiekurs Edwards Lifesciences Corp. i USDPUSH CHART

Kurs 160,05 USD -4,02 -2,45 %
Tid 21:59:51
Datum 14.12.2018
Öppning 162,57
Gårdagen 164,07
Dagshögsta 163,39
Dagslägsta 159,52
52 v. högsta 174,93
52 v. lägsta 110,70
52 v. perf.
Volym (Antal) 62 298
Börsvärde (SEK) 310,61 Mrd
Börsen
Kurs för 160,05 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 1 450,12 SEK.

Till aktien Edwards Lifesciences

Ticker
ISIN US28176E1082
Index S&P 500

Edwards Lifesciences Nyckeltal

Börsvärde i SEK 310,61 Mrd
Free float %
Antal aktier mio. 209,05
Cashflow/aktie i lokal valuta 4,63
Bokvärde/aktie i lokal valuta 14,20
60 dagar vola 40,82
PBV

Edwards Lifesciences Historiska kurser

2018-12-14 160,05 62 298
2018-12-13 164,07 62 001
2018-12-12 163,24 60 420
2018-12-11 163,25 54 560
2018-12-10 161,95 74 161